Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Mark Germain currently holds 82,569 shares of PLURISTEM THERAPEUTICS INC (PSTI), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Mark Germain has been a net seller of PSTI stock. They have purchased $0 and sold $511.1K worth of shares.
Mark Germain's most recent insider trade was on Sep 10, 2020, when they sold 20,000 shares at $0.00 per share.
Mark Germain serves as Executive at PLURISTEM THERAPEUTICS INC (PSTI). They have executed 52 insider transactions totaling $511.1K over their tenure at the company.
Mark Germain holds the position of Executive at PLURISTEM THERAPEUTICS INC, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 19 years and currently hold a stake valued at $0.
Mark Germain has shown a selling trading pattern, with $0 in total purchases and $511.1K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Mark Germain was on Dec 17, 2007, when they sold $446.8K worth of REIS shares. This transaction involved 64,944 shares at $6.88 per share.
Mark Germain currently owns 82,569 shares of PLURISTEM THERAPEUTICS INC (PSTI), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Mark Germain's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Mark Germain has 52 Form 4 filings on record as an insider at PLURISTEM THERAPEUTICS INC.
Set alerts for Mark Germain and 40,000+ other insiders.